In this issue: the rise of dark factories in medtech manufacturing, hospital cybersecurity, the sterile processing evolution, ...
Johnson & Johnson today reported fourth quarter results that beat The Street on sales but only matched on earnings.
J&J grows MedTech sales 6.1% in 2025, driven by cardiovascular and surgical products, and advances its robotic surgical ...
Medtech dealmaking rebounded last year, and, in 2026, M&A players are seeking to “outperform the next-best owner” amid softer valuations for assets. | Bain & Company’s new 2026 global M&A report found ...
Cardiovascular was the only business unit to grow by double digits last year, helping to fuel the overall medical device business to top $33 billion.
Johnson & Johnson MedTech, with support from the Johnson & Johnson Foundation, says it has donated $100 million of medtech ...
Some of medtech's most innovative technologies were on display at the Consumer Electronics Show (CES) in Las Vegas this week.
To request a meeting with Senseonics, investors should contact their BTIG representatives. About Senseonics Senseonics Holdings, Inc. (“Senseonics”) is a medical technology company focused on the ...
TD Cowen analysts Mathew Blackman and Drew Ranieri have named their top three medtech picks under their evolving “Bones, Bots ...
FastWave Medical used 2025 to make uncommon progress for an early-stage company, advancing not one but two differentiated IVL ...
Beginning Feb. 2, 2026, medical technology news and analysis will be integrated into BioWorld, where curated coverage will continue as part of BioWorld’s core reporting. This transition reflects how ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results